US 12186306
Methods of treatment for cystic fibrosis
granted A61KA61K31/395A61K31/404
Quick answer
US patent 12186306 (Methods of treatment for cystic fibrosis) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/395, A61K31/404, A61K31/4045, A61K31/4375